Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Oct 7, 2015; 21(37): 10669-10674
Published online Oct 7, 2015. doi: 10.3748/wjg.v21.i37.10669
Table 1 The trend of annual antibiotic resistance rates in the treatment of Helicobacter pylori
Patient numberProportion(95%CI) (%)P value
(χ2 test for linear trend)
Amoxicillin20100/240 (-)-
20110/320 (-)
20120/200 (-)
20130/200 (-)
20140/410 (-)
Clarithromycin201017/2470.8 (51.2-90.4)0.736
201121/3265.6 (48.2-83.0)
201213/2065.0 (42.1-87.9)
201315/2075.0 (54.2-95.8)
201429/4170.7 (57.9-85.3)
Levofloxacin20109/2437.5 (16.6-58.4)0.391
201111/3234.4 (17.0-51.8)
20126/2030.0 (8.0-52.0)
20137/2035.0 (12.1-57.9)
201411/4126.8 (7.9-41.0)
Metronidazole20109/2437.5 (16.6-58.4)0.312
20118/3225.0 (9.1-40.9)
20126/2030.0 (8.0-52.0)
20136/2030.0 (8.0-52.0)
201418/4143.9 (23.3-59.8)
Tetracycline20100/240 (-)0.556
20110/320 (-)
20122/2010.0 (0-24.4)
20130/200 (-)
20141/412.4 (0-7.4)